Metabolic Factors and Breast Cancer Recurrence
Study Overview
Norwegian researchers, led by Trygve Lofterød, have identified potential links between various metabolic factors and breast cancer recurrence and survival in a recent study published in BMC Cancer. Breast cancer remains the most prevalent cancer among women, leading to numerous fatalities annually. Advances in the identification of different breast cancer types have contributed to improved treatment outcomes and patient survival rates.
Understanding Metabolic Influences
While obesity and other metabolic factors are known to influence the overall incidence of breast cancer, the specific effects of metabolic elements such as HDL cholesterol and triglycerides on various breast cancer types and recurrence remain unclear. Gaining insights into these relationships is crucial for enhancing long-term treatment strategies for breast cancer patients.
Research Methodology
The study followed 464 Norwegian women with confirmed invasive breast cancer diagnoses. These patients’ data were sourced from a comprehensive chronic disease study conducted from 1979 to 2008. Researchers analyzed blood samples for total cholesterol, HDL cholesterol, and triglycerides, and examined tumor samples to assess tumor characteristics. They also monitored patient survival following cancer treatment.
Study Findings
During the follow-up period, 129 women died, with slightly over half of these deaths attributed to breast cancer. The predominant type of breast cancer observed was Luminal A, associated with improved survival rates and smaller tumor sizes.
Interestingly, triglycerides, total cholesterol, and HDL cholesterol levels did not correlate with overall mortality or with Luminal A or B cancer types. However, among patients with triple-negative breast cancer, those exhibiting high triglycerides faced an average mortality risk three times greater and had a 20% lower survival rate compared to those with low triglyceride levels. Conversely, patients with this subtype and elevated HDL cholesterol experienced a 67% reduction in mortality risk. Additionally, HER2-positive breast cancer patients with high triglycerides had an 86% lower mortality risk compared to those with lower triglyceride levels.
Implications of HDL and Triglyceride Levels
HDL cholesterol has been associated with aggressive tumors and tumor-promoting inflammatory cells. Nevertheless, it may also serve an antagonistic role against tumors by inhibiting the formation of blood vessels within them. Triglycerides, on the other hand, might indicate ongoing low-level inflammation, which is linked to increased cancer severity.
Future Directions
Further research is essential to elucidate why different breast cancer types display varying relationships with patients’ metabolic characteristics. Understanding these mechanisms will be critical in enhancing patient survival rates, improving prognoses, and predicting the likelihood of breast cancer recurrence.
Reference
Lofterod et al. 2018. Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes. BMC Cancer 18:654.